Oncogenic mutations in histologically normal endometrium: the new normal?

Vivian Lac, Tayyebeh M Nazeran, Basile Tessier‐Cloutier, Rosalia Aguirre-Hernandez, Rosalía Aguirre-Hernández, Arianne Albert, Amy Lum, Jaswinder Khattra, Teresa Praetorius, Madeline Mason, Derek S. Chiu, Derek Chiu, Martin Köbel, Paul J Yong, Blake C Gilks, Michael S. Anglesio, David G Huntsman
The Journal of Pathology · 2019 · vol. 249(2) , pp. 173–181 · doi:10.1002/path.5314 · PMID:31187483 · W2949413659
article OA: closed CC0 ⤵ 56 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

Somatic driver mutations, including KRAS, PIK3CA, and FGFR2, were found in over 50% of histologically normal endometrial samples, increasing with age, suggesting widespread clonal pockets of oncogenic mutations in normal endometrium.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The advent of next generation sequencing has vastly improved the resolution of mutation detection, thereby both increasing the resolution of the analysis of cancer tissues and shining light on the existence of somatic driver mutations in normal tissues, even in the absence of cancer. Studies have described somatic driver mutations in normal skin, blood, peritoneal washings, and esophageal epithelium. Such findings prompt speculation on whether such mutations exist in other tissues, such as the eutopic endometrium in particular, due to the highly regenerative nature of the endometrium and the recent observation of recurrent somatic driver mutations in deep infiltrating and iatrogenic endometriosis (tissues believed to be derived from the eutopic endometrium) by our group and others. In the current study we investigated the presence of somatic driver mutations in histologically normal endometrium from women lacking evidence of gynecologic malignancy or endometrial hyperplasia. Twenty-five women who underwent hysterectomies and 85 women who underwent endometrial biopsies were included in this study. Formalin-fixed, paraffin-embedded tissue specimens were analyzed by means of targeted sequencing followed by orthogonal validation with droplet digital PCR. PTEN and ARID1A immunohistochemistry (IHC) was also performed as surrogates for inactivating mutations in the respective genes. Overall, we observed somatic driver-like events in over 50% of normal endometrial samples analyzed, including hotspot mutations in KRAS, PIK3CA, and FGFR2 as well as PTEN-loss by IHC. Analysis of anterior and posterior samplings collected from women who underwent hysterectomies was consistent with the presence of somatic driver mutations within clonal pockets spread throughout the uterus. The prevalence of such oncogenic mutations also increased with age (OR: 1.05 [95% CI: 1.00-1.10], p = 0.035). These findings have implications on our understanding of aging and so-called 'normal tissues', thereby necessitating caution in the utilization of mutation-based early detection tools for endometrial or other cancers. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Aging DNA Mutational Analysis Early Detection of Cancer Endometrial Neoplasms Endometrium Mutation Oncogenes Adult Age Factors Aging Aging Early Detection of Cancer Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Endometrium Female Healthy Volunteers Humans Middle Aged

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (48)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:22:48.502547+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK